Organovo Holdings (STU:4OR1) Total Assets : €5.84 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Organovo Holdings Total Assets?

Organovo Holdings's Total Assets for the quarter that ended in Mar. 2024 was €5.84 Mil.

During the past 12 months, Organovo Holdings's average Total Assets Growth Rate was -19.90% per year. During the past 3 years, the average Total Assets Growth Rate was 10.50% per year. During the past 5 years, the average Total Assets Growth Rate was 11.50% per year. During the past 10 years, the average Total Assets Growth Rate was -0.40% per year.

During the past 13 years, Organovo Holdings's highest 3-Year average Total Assets Growth Rate was 1087.20%. The lowest was -44.70%. And the median was 16.35%.

Total Assets is connected with ROA %. Organovo Holdings's annualized ROA % for the quarter that ended in Mar. 2024 was -160.23%. Total Assets is also linked to Revenue through Asset Turnover. Organovo Holdings's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

Organovo Holdings Total Assets Historical Data

The historical data trend for Organovo Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organovo Holdings Total Assets Chart

Organovo Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Assets

Get a 7-Day Free Trial

25.74

33.53

30.23

18.97

5.84

Organovo Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															18.97	13.62	10.46	8.14	5.84

Organovo Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Organovo Holdings's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (A: Mar. 2024 )	+	Total Liabilities (A: Mar. 2024 )
	=	3.313	+	2.528
	=	5.84

Organovo Holdings's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	3.313	+	2.528
	=	5.84

Organovo Holdings (STU:4OR1) Total Assets Explanation

Total Assets is connected with ROA %.

Organovo Holdings's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-11.204	/	( (8.144	+	5.841)	/ 2 )
	=	-11.204	/	6.9925
	=	-160.23 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Organovo Holdings's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0.027	/	( (8.144	+	5.841)	/ 2 )
=	0.027	/	6.9925
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Organovo Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Organovo Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Organovo Holdings (STU:4OR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Organovo Holdings Inc (STU:4OR1) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

ONVO:USA

Address

11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121

Website

https://www.organovo.com

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Organovo Holdings (STU:4OR1) Headlines

No Headlines